Penn Medicine Abramson Cancer Center


 

2020 ASCO Update on Prostate Cancer: How Effective Are Recently FDA Approved Olaparib & Rucaparib for mCRPC With HRR-gene Defects? Does a Novel GnRH Antagonist Relugolix Look Promising?

0 views
July 15, 2020
Comments 0
Login to view comments. Click here to Login